Premaitha eyes genetic test
Patient investors looking to gain exposure to a potential game-changing product should look at genetic analysis specialist Premaitha Health (NIPT:AIM).The Manchester-based company has developed IONA, a non-invasive pre-natal test to...
20 November 2014
